Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

The company had previously lowered its revenue guidance in August 2024 by 2%-3% due to weaker instrument demand, meaning the year-over-year decline was on the lower end of this range. Illumina ...

Our illumina HiSeq 2500 platform supports a variety of different experiments, including whole-genome and candidate-region sequencing, transcriptome analysis, small RNA discovery, methylation profiling ...

NEW YORK, Jan 13 (Reuters) - Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals (REGN.O), opens new tab, Illumina (ILMN.O), opens new ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Trading Basic Education Trading Platforms & Tools Trading Orders Risk Management Trading Psychology ...